Table 1.
iXLT |
XLT |
WAS |
||||
---|---|---|---|---|---|---|
Score | <1 | 1 | 2 | 3 | 4 | 5 |
Thrombocytopenia | −/+ | + | + | + | + | + |
Small platelets | + | + | + | + | + | + |
Eczema | − | − | (+) | + | ++ | (+)/+/++ |
Immunodeficiency | − | −/(+) | (+) | + | + | (+)/+ |
Infections | − | − | (+) | + | +/++ | (+)/+/++ |
Autoimmunity and/or malignancy | − | − | − | − | − | + |
iXLT, intermittent X-linked thrombocytopenia
Scoring system: −, absent; (+), mild; +, present; ++, present and severe
Patients who develop a score 5 are defined as 5A if they present autoimmunity, and 5M if they develop malignancies.
Patients may change their score during life-time. In particular, patients with XLT may progress to WAS and may occasionally reach a score of 5.
(Modified from: Ochs et al., 2009).